Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Metformin Generics Are "Approvable"; Barr Says Delay Helps Other Generics

Executive Summary

The delay in FDA approval of generic versions of Bristol-Myers Squibb's Glucophage (metformin) will reduce Barr's profitability from the product by giving other generic companies time to increase their manufacturing capacity, Barr said.

You may also be interested in...



Glucophage Generics Enter Market: Bristol Says It Will Not Sue Agency

Generic versions of metformin will carry labeling that refers prescribers to Bristol-Myers Squibb's Glucophage label for information on pediatric patients

Glucophage Generics Enter Market: Bristol Says It Will Not Sue Agency

Generic versions of metformin will carry labeling that refers prescribers to Bristol-Myers Squibb's Glucophage label for information on pediatric patients

Bristol Metformin/Glyburide Patent Could Extend Glucophage Exclusivity

Bristol has a patent application pending that covers low-dose combinations of metformin (Glucophage) and glyburide

Related Content

UsernamePublicRestriction

Register

PS038669

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel